In-vitro cidal activity of clarithromycin and its 14-hydroxy metabolite (A-62671) against Haemophilus influenzae.
Powell
M
M
Chen
H Y
HY
Weinhardt
B
B
Williams
J D
JD
D017291:Clarithromycin / Q000031:analogs & derivatives; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination / Q000494:pharmacology; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D013997:Time Factors
C056228:14-hydroxyclarithromycin; D004917:Erythromycin; D017291:Clarithromycin